Sort   by:  
 Page size 
UnknownThe necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC.
Not available
S-EPMC10169569 | biostudies-literature
UnknownSEL1L confers reduced EMT and drug resistance to breast cancer cells by promoting Shh degradation.
Not available
S-EPMC12648483 | biostudies-literature
UnknownAssociation of carbon monoxide poisoning with cardiovascular disease risk: A systematic review and meta-analysis.
Not available
S-EPMC11305204 | biostudies-literature
UnknownCombining ropivacaine transversus abdominis plane block with intravenous lidocaine infusion in adults undergoing colorectal cancer surgery: an open-label, dose-escalation exploratory trial.
Not available
S-EPMC12281678 | biostudies-literature
UnknownThe impact of EGFR T790M mutation status following the development of Osimertinib resistance on the efficacy of Osimertinib in non-small cell lung cancer: A meta-analysis.
Not available
S-EPMC10999367 | biostudies-literature
UnknownComparison of osimertinib plus bevacizumab against osimertinib alone in NSCLC harboring EGFR mutations: a systematic review and meta-analysis.
Not available
S-EPMC10832416 | biostudies-literature
UnknownPD-1 Inhibitor Combined With Radiotherapy and GM-CSF (PRaG) in Patients With Metastatic Solid Tumors: An Open-Label Phase II Study.
Not available
S-EPMC9304897 | biostudies-literature
UnknownDisulfidptosis-related genes RPN1 inhibits the progression of hepatocellular carcinoma by regulating cell cycle, may be a new therapeutic targets.
Not available
S-EPMC12279901 | biostudies-literature
UnknownAn immune-based predictive model for HBV clearance: validation in multicenter cohorts and mechanistic insights from in vivo studies.
Not available
S-EPMC12096729 | biostudies-literature
UnknownPD-L1 expression is a promising predictor of survival in patients with advanced lung adenocarcinoma undergoing pemetrexed maintenance therapy.
Not available
S-EPMC7527332 | biostudies-literature
Sort   by:  
 Page size